Kristen Van Dole is a Neurosciences Epidemiologist in the Worldwide Epidemiology Department at GlaxoSmithKline. In this role, Kristen is responsible for supporting several marketed compounds and complying with regulatory post-marketing commitments, as well as developing innovate methods for pharmacovigilance studies. Prior to joining GlaxoSmithKline, Kristen served as an Epidemiology reviewer at the FDA in the Center for Devices and Radiological Health. Kristen's interests lie within the research of patient reported outcomes and survey development within the epidemiologic field. She received her MSPH and PhD in Epidemiology from the University of North Carolina at Chapel Hill.